Sun Pharma Advanced Research Company Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 532872 |
NSE Symbol : SPARC |
P/E(TTM) : - |
ISIN Demat : INE232I01014 |
Div & Yield% : - |
EPS(TTM) : - |
Book Value(₹) : 3.85 |
Market Cap(₹Cr) : 7,092.42 |
Face Value(₹) : 1.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 16.81 | 16.56 | 13.86 | 21.18 | 23.95 | 47.69 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 16.81 | 16.56 | 13.86 | 21.18 | 23.95 | 47.69 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.56 | 4.40 | 6.39 | 8.49 | 10.19 | 10.73 |
Total Income | 18.37 | 20.96 | 20.25 | 29.67 | 34.14 | 58.42 |
Total Expenditure | 111.93 | 124.08 | 116.48 | 112.65 | 126.13 | 137.26 |
PBIDT | -93.56 | -103.12 | -96.23 | -82.98 | -91.99 | -78.84 |
Interest | 0.52 | 0.88 | 0.26 | 0.26 | 0.26 | 0.21 |
PBDT | -94.08 | -104.00 | -96.49 | -83.24 | -92.25 | -79.05 |
Depreciation | 2.76 | 2.69 | 3.16 | 3.18 | 3.10 | 2.94 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | -96.84 | -106.69 | -99.65 | -86.42 | -95.35 | -81.99 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | -96.84 | -106.69 | -99.65 | -86.42 | -95.35 | -81.99 |
EPS (Unit Curr.) | -2.98 | -3.29 | -3.07 | -2.66 | -2.94 | -2.55 |
EPS (Adj) (Unit Curr.) | -2.98 | -3.29 | -3.07 | -2.66 | -2.94 | -2.55 |
Calculated EPS (Unit Curr.) | -2.98 | -3.29 | -3.07 | -2.66 | -2.94 | -2.53 |
Calculated EPS (Adj) (Unit Curr.) | -2.98 | -3.29 | -3.07 | -2.66 | -2.94 | -2.53 |
Calculated EPS (Ann.) (Unit Curr.) | -11.94 | -13.15 | -12.28 | -10.65 | -11.75 | -10.11 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | -11.94 | -13.15 | -12.28 | -10.65 | -11.75 | -10.11 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | -556.57 | -622.71 | -694.30 | -391.78 | -384.09 | -165.32 |
PBDTM(%) | -559.67 | -628.02 | -696.18 | -393.01 | -385.18 | -165.76 |
PATM(%) | -576.09 | -644.26 | -718.98 | -408.03 | -398.12 | -171.92 |